People diagnosed with hairy cell leukemia (HCL) may have an effective new treatment option, a type of drug called an immunotoxin. Read more about how this treatment, moxetumomab pasudotox, faired in a phase 3 clinical trial in patients with advanced HCL.
https://ift.tt/2JdqHRt
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου